Overview
- Health officials report 28 suspected infections and 15 deaths in Bulape and Mweka, with four fatalities among health workers.
- Laboratory testing at the National Institute of Biomedical Research in Kinshasa confirmed the Zaire ebolavirus on September 3.
- WHO and Africa CDC have joined Congo’s Rapid Response Team, deploying experts, mobile lab capacity and two tonnes of protective gear and medical supplies.
- About 2,000 doses of the Ervebo vaccine stored in Kinshasa are being moved to Kasai to vaccinate contacts and frontline health workers.
- The affected area is remote with limited air links and at least a day’s drive from Tshikapa, and WHO cautions that transmission is ongoing with case counts likely to rise.